Synchron, a competitor to Neuralink, has announced one of its patients with ALS is now able to control devices using only his mind with its brain chip implant.
Close to half of the AI devices authorized for use by the U.S. Food and Drug Administration (FDA) are trained without using clinical data from actual patients, according to new findings by an international team of researchers.
Researchers from the University of Reading and King's College London say they are finding what constitutes the ideal “computer whiz” student among young people.
Neuralink has implanted its experimental N1 brain-computer interface (BCI) within a second patient, with Elon Musk, the company's CEO, saying the procedure is “working very well.”
Neuralink recently revealed that it chose to postpone the insertion of a second brain chip implant in a procedure that had been eagerly anticipated by the medical and tech communities.
The FDA has approved Elon Musk's Neuralink to implant its experimental brain chip technology in a second individual, following issues that arose with its first patient.